Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
Aspergillus spp.
Candida
ECOFFS
ECVs
ERG11 mutants
amphotericin B
antifungal resistance
caspofungin
nonprevalent Candida
triazoles
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
18 10 2021
18 10 2021
Historique:
pubmed:
10
8
2021
medline:
3
11
2021
entrez:
9
8
2021
Statut:
ppublish
Résumé
Susceptibility testing is an important tool in the clinical setting; its utility is based on the availability of categorical endpoints, breakpoints (BPs), or epidemiological cutoff values (ECVs/ECOFFs). CLSI and EUCAST have developed antifungal susceptibility testing, BPs, and ECVs for some fungal species. Although the concentration gradient strip bioMérieux Etest is useful for routine testing in the clinical laboratory, ECVs are not available for all agent/species; the lack of clinical data precludes development of BPs. We reevaluated and consolidated Etest data points from three previous studies and included new data. We defined ECOFFinder Etest ECVs for three sets of species-agent combinations: fluconazole, posaconazole, and voriconazole and 9
Identifiants
pubmed: 34370582
doi: 10.1128/AAC.01093-21
pmc: PMC8522771
doi:
Substances chimiques
Antifungal Agents
0
Triazoles
0
Amphotericin B
7XU7A7DROE
Caspofungin
F0XDI6ZL63
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0109321Références
Diagn Microbiol Infect Dis. 2010 Apr;66(4):373-84
pubmed: 20226328
J Antimicrob Chemother. 2017 Apr 1;72(4):988-992
pubmed: 28065893
Antimicrob Agents Chemother. 2014 Nov;58(11):6807-18
pubmed: 25182640
Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33495222
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60
pubmed: 27365388
J Fungi (Basel). 2021 Jan 04;7(1):
pubmed: 33406771
J Clin Microbiol. 2001 Jan;39(1):339-42
pubmed: 11136795
J Antimicrob Chemother. 2020 May 1;75(5):1194-1205
pubmed: 32025716
Rev Iberoam Micol. 2016 Apr-Jun;33(2):63-75
pubmed: 27296911
Clin Microbiol Infect. 2006 May;12(5):418-25
pubmed: 16643517
Clin Microbiol Infect. 2019 Dec;25(12):1546-1552
pubmed: 31082487
Antimicrob Agents Chemother. 2011 Jun;55(6):2855-9
pubmed: 21422219
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28807920
Antimicrob Agents Chemother. 2015 Jan;59(1):450-60
pubmed: 25385095
J Fungi (Basel). 2019 Nov 22;5(4):
pubmed: 31766762
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30323038
Antimicrob Agents Chemother. 2015 Dec;59(12):7715-22
pubmed: 26438490
Med Mycol. 2016 Jan;54(1):80-8
pubmed: 26591008
J Clin Microbiol. 2021 Jan 21;59(2):
pubmed: 33028600
Nat Rev Microbiol. 2020 Jun;18(6):319-331
pubmed: 32047294
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38
pubmed: 29544767
Nat Rev Dis Primers. 2018 May 11;4:18026
pubmed: 29749387
Antimicrob Agents Chemother. 2013 Dec;57(12):5836-42
pubmed: 24018263
Emerg Infect Dis. 2015 Nov;21(11):1942-50
pubmed: 26488845
Antimicrob Agents Chemother. 2013 Oct;57(10):4769-81
pubmed: 23877676
Clin Infect Dis. 2016 Feb 15;62(4):e1-50
pubmed: 26679628
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27799206
Antimicrob Agents Chemother. 2005 Feb;49(2):668-79
pubmed: 15673750
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37
pubmed: 23137135
Antimicrob Agents Chemother. 2001 Oct;45(10):2676-84
pubmed: 11557454